Maini, Mala K.
Bertoletti, Antonio
Article History
First Online: 5 January 2017
Competing interests
: M.K.M. lab has received research funding from Gilead and Roche, and has served as a consultant and on advisory boards for BMS, Galapagos, Gilead, ITS, Medimmune, Roche and Transgene. A.B. collaborates and receives research support from Gilead. He acted as a consultant and served on the advisory boards of Abivax, Gilead, Humabs BioMed, Jansseen-Cilag, Medimmune. A.B. is also a co-founder of LION TCR, a biotech company developing T-cell receptors for treatment of virus-related cancers and chronic viral diseases.